David Turkaly
Stock Analyst at Citizens
(2.26)
# 2,713
Out of 5,124 analysts
144
Total ratings
42.42%
Success rate
-2.61%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Upgrades: Market Outperform | $440 | $351.47 | +25.19% | 4 | Dec 19, 2025 | |
| TELA TELA Bio | Maintains: Market Outperform | $7 → $5 | $1.18 | +323.73% | 7 | Nov 14, 2025 | |
| APYX Apyx Medical | Upgrades: Market Outperform | $8 | $3.50 | +128.57% | 6 | Nov 12, 2025 | |
| AXGN Axogen | Maintains: Market Outperform | $26 → $34 | $32.73 | +3.88% | 8 | Oct 30, 2025 | |
| KIDS OrthoPediatrics | Maintains: Market Outperform | $35 → $25 | $17.79 | +40.53% | 12 | Oct 10, 2025 | |
| LNTH Lantheus Holdings | Maintains: Market Outperform | $112 → $73 | $66.55 | +9.69% | 9 | Aug 7, 2025 | |
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $15.16 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $87.31 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $80.15 | +24.77% | 12 | May 20, 2025 | |
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $253.52 | +10.44% | 18 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $35 → $25 | $12.42 | +101.29% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $62 → $55 | $26.64 | +106.46% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $140 → $125 | $89.92 | +39.01% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $400 → $500 | $468.76 | +6.66% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $122.04 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $19.72 | +62.27% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $8.07 | +98.27% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $1.38 | +117.39% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $9.40 | -46.81% | 1 | Oct 6, 2017 |
Stryker
Dec 19, 2025
Upgrades: Market Outperform
Price Target: $440
Current: $351.47
Upside: +25.19%
TELA Bio
Nov 14, 2025
Maintains: Market Outperform
Price Target: $7 → $5
Current: $1.18
Upside: +323.73%
Apyx Medical
Nov 12, 2025
Upgrades: Market Outperform
Price Target: $8
Current: $3.50
Upside: +128.57%
Axogen
Oct 30, 2025
Maintains: Market Outperform
Price Target: $26 → $34
Current: $32.73
Upside: +3.88%
OrthoPediatrics
Oct 10, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $17.79
Upside: +40.53%
Lantheus Holdings
Aug 7, 2025
Maintains: Market Outperform
Price Target: $112 → $73
Current: $66.55
Upside: +9.69%
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $15.16
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $87.31
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $80.15
Upside: +24.77%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $253.52
Upside: +10.44%
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $12.42
Upside: +101.29%
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $26.64
Upside: +106.46%
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $89.92
Upside: +39.01%
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $468.76
Upside: +6.66%
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $122.04
Upside: -
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $19.72
Upside: +62.27%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $8.07
Upside: +98.27%
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $1.38
Upside: +117.39%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $9.40
Upside: -46.81%